UPDATE : Monday, December 17, 2018
상단여백
GC’s Q3 sales fell to ₩352.3 billion won
GC said Tuesday that the company and its subsidiaries recorded 352.3 billio...
by Lee Han-soo  |  2018-10-30 17:00
라인
[Exclusive] Patent of osteoarthritis drug Invossa refused in Europe
Kolon TissueGene has failed to obtain a patent for Korea’s 29th novel drug ...
by Nam Doo-hyun  |  2018-10-30 16:04
라인
Hanmi’s partner gets FDA nod for testing oral breast cancer treatment
Hanmi Pharmaceutical said Tuesday that Athenex, its U.S. partner, has recei...
by Lee Han-soo  |  2018-10-30 16:00
라인
Generics threaten originals in dementia drug market
Generic products are showing tremendous growth in the market of Donepezil, ...
by So Jae-hyeon  |  2018-10-30 14:18
라인
Hanmi posts ₩235.3 billion in Q3 sales
Hanmi Pharmaceutical said Monday that it recorded sales of 235.3 billion wo...
by Lee Han-soo  |  2018-10-30 11:14
라인
ViiV Healthcare asks FDA to approve new HIV treatment
ViiV Healthcare has submitted a new drug application (NDA) to the U.S. Food...
by Lee Han-soo  |  2018-10-29 16:53
라인
‘Foreign investors fear Korean botox sales decline in China’
Foreign institutional investors fear that Korean makers of botulinum toxin ...
by Nam Doo-hyun  |  2018-10-29 16:52
라인
HanAll releases test results for dry eye treatment in US
HanAll Biopharma said Monday it has presented phase 2 clinical trial result...
by Lee Han-soo  |  2018-10-29 16:08
라인
JW invests in Argonaut Therapeutics
JW Pharmaceutical said Monday that it has signed a strategic investment agr...
by Lee Han-soo  |  2018-10-29 11:16
라인
AbbVie unveils P2-b clinical trial results for ulcerative colitis treatment
AbbVie said Friday that it has produced positive results from U-ACHIEVE, an...
by Lee Han-soo  |  2018-10-26 17:44
라인
Pfizer’s generic business turn ‘disastrous’ amid cancer controversy
Multinational pharmaceutical giant Pfizer’s generic business in Korea is no...
by So Jae-hyeon  |  2018-10-26 17:14
라인
SCM Lifescience gets ₩5.5 billion investment from Malaysia
SCM Lifescience said Thursday that it has received a 5.5 billion won ($4.8 ...
by Lee Han-soo  |  2018-10-26 15:00
라인
Ministry OKs phase-3a clinical trial for new anti-diabetes drug
Novo Nordisk said it would conduct phase 3a clinical trial for Ozempic in K...
by Lee Hye-seon  |  2018-10-26 14:18
라인
Hugel posts ₩34.9 billion in Q3 sales
Hugel said Thursday that it recorded sales of 34.9 billion won ($30.6 milli...
by Lee Han-soo  |  2018-10-26 13:49
라인
Viromed unveils reaction principle of VM202
ViroMed said Thursday that it has published the bell-shaped drug dose respo...
by Lee Han-soo  |  2018-10-25 17:21
라인
Daewoong releases research results for 2 drug candidates in US
Daewoong Pharmaceutical said Thursday that it has presented the trial resul...
by Lee Han-soo  |  2018-10-25 16:30
라인
Boehringer, Lilly unveil clinical results for diabetes treatment
Boehringer Ingelheim and Eli Lilly have published a new analysis on EMPA-RE...
by Lee Han-soo  |  2018-10-25 15:08
라인
‘Handok encouraged unlicensed medical practice for pharmacists’
Pharmaceutical firm Handok allegedly encouraged pharmacists to carry out un...
by So Jae-hyeon  |  2018-10-25 15:06
라인
Ono Pharma Korea rebuked for late reporting of adverse events
The Ministry of Food and Drug Safety issued a warning to Ono Pharma Korea f...
by Lee Hye-seon  |  2018-10-25 13:55
라인
Novartis struggles to restore sales of Alzheimer’s drug Exelon
Novartis has failed to restore the sales of Exelon, a patch for the treatme...
by Nam Doo-hyun  |  2018-10-25 11:04
여백
여백
여백
Back to Top